# CYTOKINETICS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cytokinetics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:37.386881+00:00 | | Last reviewed | 2026-10-17T04:45:37.386881+00:00 | ## Identity - Legal name: CYTOKINETICS INC - Display name: CYTOKINETICS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T11:04:50.661515+00:00 | | Completeness | 0.409 | | Record Quality | 0.84 | | Directors | 4 | | Committees | 4 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Edward M. Kaye: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:6 - James M. Daly: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:7 - Richard Landry: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member). claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:8 - Wendell Wierenga: Director. Status: current. Independent: true. Since: 2011-01-01. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:9 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Richard Landry (member, current). committee_id=alpha:committee:cytokinetics-inc:audit - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Edward M. Kaye (member, current). committee_id=alpha:committee:cytokinetics-inc:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Edward M. Kaye (member, current). committee_id=alpha:committee:cytokinetics-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Edward M. Kaye (member, current). committee_id=alpha:committee:cytokinetics-inc:nominating-and-governance ## Executive leadership - Andrew M. Callos: Executive Vice President, Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:10 - Fady I. Malik: Executive Vice President, Research and Development. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:11 - Jeffrey J. Hessekiel: Executive Vice President, Chief Legal and Administrative Officer. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:12 - Robert I. Blum: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:13 - Stephen Lee: Executive Vice President, Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:14 - Sung H. Lee: Executive Vice President, Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:15 ## Governance events - EXECUTIVE_APPOINTED: Andrew M. Callos executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:15c58to1u37ags - EXECUTIVE_APPOINTED: Fady I. Malik executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:av31xm21j270 - EXECUTIVE_APPOINTED: Jeffrey J. Hessekiel executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:w7tdz81dbqvo - CEO_CHANGED: Robert I. Blum executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1ig1n9pcbh7oh - CFO_CHANGED: Stephen Lee executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:1bu7rfc4jvvu2 - CFO_CHANGED: Sung H. Lee executive of CYTOKINETICS INC, effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:11i1odatqzcs6 - DIRECTOR_APPOINTED: James M. Daly seat on CYTOKINETICS INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:118cxonxwocx - DIRECTOR_APPOINTED: Richard Landry seat on CYTOKINETICS INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:jg33io1jfxn0e - COMMITTEE_MEMBER_ADDED: Richard Landry member of Audit, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:och72pdi6b2 - DIRECTOR_APPOINTED: Edward M. Kaye seat on CYTOKINETICS INC, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:14qspte1wawl1c - COMMITTEE_CREATED: Compensation; Nominating and Governance committee of CYTOKINETICS INC, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:hj5syo1fwl2mc - COMMITTEE_MEMBER_ADDED: Edward M. Kaye member of Compensation; Nominating and Governance, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:2n0z7t162ls0z - DIRECTOR_APPOINTED: Wendell Wierenga seat on CYTOKINETICS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-17T04:45:37.386881+00:00. event_id=alpha:event:transition:am5qtw14x8qc4 ## Scoped resources - `alpha://company/cytokinetics-inc` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record - `alpha://company/cytokinetics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=identity - `alpha://company/cytokinetics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=corporate-structure - `alpha://company/cytokinetics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=board - `alpha://company/cytokinetics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=committees - `alpha://company/cytokinetics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=leadership - `alpha://company/cytokinetics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=ownership - `alpha://company/cytokinetics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=financials - `alpha://company/cytokinetics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=capital-structure - `alpha://company/cytokinetics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=compensation - `alpha://company/cytokinetics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=governance - `alpha://company/cytokinetics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=shareholder-governance - `alpha://company/cytokinetics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=audit - `alpha://company/cytokinetics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=legal - `alpha://company/cytokinetics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=risk - `alpha://company/cytokinetics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=cyber - `alpha://company/cytokinetics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=ai-governance - `alpha://company/cytokinetics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=agents - `alpha://company/cytokinetics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=ecosystem - `alpha://company/cytokinetics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=events - `alpha://company/cytokinetics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=relationships - `alpha://company/cytokinetics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=assessments - `alpha://company/cytokinetics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:robert-e-landry","name":"Richard Landry"},"source_id":"board_seats"}` - Claim alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:edward-m-kaye","name":"Edward M. Kaye"},"source_id":"board_seats"}` - Claim alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:edward-m-kaye","name":"Edward M. Kaye"},"source_id":"board_seats"}` ## Leadership - Edward M. Kaye: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38775b185daa7393e491af0c78db075963e9e3031ab1f19ac15e4c3603250c1d. - James M. Daly: Director. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38775b185daa7393e491af0c78db075963e9e3031ab1f19ac15e4c3603250c1d. - Richard Landry: Director, Audit. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38775b185daa7393e491af0c78db075963e9e3031ab1f19ac15e4c3603250c1d. - Wendell Wierenga: Director. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:9. Valid from: 2011-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38775b185daa7393e491af0c78db075963e9e3031ab1f19ac15e4c3603250c1d. - Andrew M. Callos: Executive Vice President, Chief Commercial Officer. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:10. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:874ffd2bfda9776ac08a1956166fcb1ca78c80ff3d4863389476e8d07fcdcb62. - Fady I. Malik: Executive Vice President, Research and Development. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:11. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9e259728b2b798ebe2de5c93788522dc9a1f5d92dbfc34afa403db823475bf1. - Jeffrey J. Hessekiel: Executive Vice President, Chief Legal and Administrative Officer. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:12. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a7e7735ddc4218e5074432d1e556b4c49c5d874f7e1ad40ef252bdbd37f6966d. - Robert I. Blum: President and Chief Executive Officer. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:13. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a34bafb6d8d8dad858fa7024662707a28bded13197b2a92b325774e9198b742f. - Stephen Lee: Executive Vice President, Chief Financial Officer. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:14. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fc8451f730ec10d80c330b107bb6cd953ee3e4db97958ad46fb2b614b4022376. - Sung H. Lee: Executive Vice President, Chief Financial Officer. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:leadership_role:15. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26afe80e577a94b3a99a1da922f9bcada011544bc94d4e8c594fdfe7a6344315. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Richard Landry. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. - Compensation: Chair not stated; Members Edward M. Kaye. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. - Nominating and Governance: Chair not stated; Members Edward M. Kaye. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - CYTOKINETICS INC. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1. ## Entity Status - Public listing published. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1. ## Published Fact - US. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1. - Healthcare. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1. ## Committee Appointment - Richard Landry: member, Audit. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. - Edward M. Kaye: member, Compensation. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. - Edward M. Kaye: member, Nominating and Governance. Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2. ## Security Listing - CYTK (NASDAQ). Claim: alpha:claim:company:cdc301e1-0844-4cdb-9e66-8aeb1b80115b:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:3116b2f57aaf36b49d921230d8cc713782122117e507477b5e9ad80b11a800e1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cytokinetics-inc). - alpha:projection-evidence:document:38775b185daa7393e491af0c78db075963e9e3031ab1f19ac15e4c3603250c1d: [Cytokinetics Inc DEF 14A 2026-04-17](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:874ffd2bfda9776ac08a1956166fcb1ca78c80ff3d4863389476e8d07fcdcb62: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:c9e259728b2b798ebe2de5c93788522dc9a1f5d92dbfc34afa403db823475bf1: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:a7e7735ddc4218e5074432d1e556b4c49c5d874f7e1ad40ef252bdbd37f6966d: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:a34bafb6d8d8dad858fa7024662707a28bded13197b2a92b325774e9198b742f: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:fc8451f730ec10d80c330b107bb6cd953ee3e4db97958ad46fb2b614b4022376: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:document:26afe80e577a94b3a99a1da922f9bcada011544bc94d4e8c594fdfe7a6344315: [CYTK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). - alpha:projection-evidence:4d05f55ffe6698182d159bfff322a157d00ed689d192ae4af1b94f72ace816d2: [Audit](https://www.sec.gov/Archives/edgar/data/1061983/000114036126015364/ny20063687x771_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cytokinetics-inc) - [Public Markdown](https://registry.alpha.ac/companies/cytokinetics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cytokinetics-inc?format=jsonld) - MCP resource: `alpha://companies/cytokinetics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T11:04:50.458323+00:00; recorded 2026-10-17T11:04:50.458323+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.